amp 579
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
We investigated the effects of 1S-[1a,2b,3b,4a(S*)]-4-[7-[[1-[(3-chloro-2-thienyl)methylpropyl]propyl-amino]-3H-imidazo[4,5-b…
The adenosine A(1)/A(2) receptor agonist AMP 579 has been reported to protect the heart against infarction even when administered…
AMP 579, an adenosine A1/A2 receptor agonist, is cardioprotective when administered at reperfusion. Pretreatment with the Na+/H…
&NA; To determine the mechanism by which AMP 579, an adenosine A1/A2 agonist, administered at reperfusion protects ischemic…
AMP 579, an adenosine A(1)/A(2) receptor agonist, has a strong anti-infarct effect when administered just before reperfusion…
The novel A(1)/A(2)adenosine receptor agonist AMP 579 has been reported to reduce myocardial infarct size in pig and dog. The…
The pharmacokinetics of an adenosine agonist (AMP 579) were characterized in patients with end‐stage renal disease compared to…
The hemodynamic and cardioprotective properties of the novel adenosine A1/A2 receptor agonist AMP 579 (IS-[1a,2b,3b,4a(S*)]-4-[7…
This study examined the cardioprotective effects and pharmacology of the novel adenosine A1/A2 receptor agonist ([1S-[1a,2b,3b…
AMP 579 1S‐[1α,2β,3β,4α(S*)]‐4‐[7‐[[1‐[(3‐chloro‐2‐thienyl)methyl]propylamino]‐3H‐imidazo[4,5‐b]pyridin‐3‐yl]‐N‐ethyl‐2,3…